Download Medical Notes on Orphan Drugs in the United States - Exclusivity, Pricing and Treated Populations

Orphan Drugs in the United States - Exclusivity, Pricing and Treated Populations Medical Notes

About This Presentation

Description:This report titled, “Orphan Drugs in the United States - Exclusivity, Pricing and Treated Populations” is by the IQVIA Institute and is an analysis of the orphan drug market. The report explores this topic of orphan drugs’ orphan and non-orphan indication approvals and their associated patent and market exclusivities. The report also examines orphan drug pricing relative to patient numbers, how those prices change over time, and – in a first-of-its-kind comprehensive analysis – compares current disease epidemiology to the number of treated patients to demonstrate the challenges in bringing orphan drugs to patients even after they are approved.

Tags:Healthcare, Orphan Drugs, United States, market, pricing, disease epidemiology

Published on: Jul 20, 2020 | Views : 1397 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

The Beginning of Human Life and Prevention of Chronic Disease: Reframing the First 1,000 Days

About : I am a passionate medical marketing professional with hands on experience in healthcare digital marketing.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : India
Website :

The Beginning of Human Life and Prevention of Chronic Disease: Reframing the First 1,000 Days

Marketing of Healthcare Services

Get the insurance companies out of my healthcare

Understanding the Positive Implications of the Placebo Effect

Where does Wellness Fit at the World Health Organization

Pharmacy Handbook to Help Technicians Overcome Key Challenges

Anti Diarrheal Drug

Orphan Drugs in the United States - Exclusivity, Pricing and Treated Populations

EvaluatePharma pharmaceutical industry world review 2019 and outlook 2024

Pharma 2020 Taxing times ahead

HEALTH A TO Z